{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:53:09Z","timestamp":1791503589329,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.carrev.2025.01.010","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:07:14Z","timestamp":1737691634000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparative analysis of the DanGer Shock trial to randomized cardiogenic shock trials and real-world registries"],"prefix":"10.1016","volume":"80","author":[{"given":"Magdi","family":"Zordok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin G.","family":"Buda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Etiwy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourbha S.","family":"Dani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarju","family":"Ganatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babar","family":"Basir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldoon","family":"Alaswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil S.","family":"Brilakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Megaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2025.01.010_bb0005","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/ejhf.1566","article-title":"Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study","volume":"21","author":"Helgestad","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.carrev.2025.01.010_bb0010","first-page":"3","article-title":"Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States","author":"Kolte","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.carrev.2025.01.010_bb0015","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/ejhf.339","article-title":"Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes","volume":"17","author":"De Luca","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.carrev.2025.01.010_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2025.01.010_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11239-005-0938-0","article-title":"Thrombolysis and Counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS trial","volume":"19","author":"Magnus Ohman","year":"2005","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.carrev.2025.01.010_bb0030","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2025.01.010_bb0035","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2025.01.010_bb0040","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","article-title":"Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock","volume":"26","author":"Thiele","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.carrev.2025.01.010_bb0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.acvd.2019.10.005","article-title":"Mechanical circulatory support with the Impella\u00ae LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: the IMPELLA-STIC randomized study","volume":"113","author":"Bochaton","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.carrev.2025.01.010_bb0050","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2025.01.010_bb0055","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2025.01.010_bb0060","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2025.01.010_bb0065","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2025.01.010_bb0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.carrev.2025.01.010_bb0075","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard Care in Infarct-Related Cardiogenic Shock","volume":"390","author":"M\u00f8ller","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2025.01.010_bb0080","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2025.01.010_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCHEARTFAILURE.112.967224","article-title":"Percutaneous left-ventricular support with the Impella-2.5\u2013assist device in acute cardiogenic shock","volume":"6","author":"Lauten","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.carrev.2025.01.010_bb0090","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.33963\/v.kp.97218","article-title":"Multicenter registry of Impella-assisted high-risk percutaneous coronary interventions and cardiogenic shock in Poland (IMPELLA-PL)","volume":"81","author":"Pietrasik","year":"2023","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.carrev.2025.01.010_bb0095","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.4244\/EIJ-D-19-00428","article-title":"Observational multicentre registry of patients treated with IMPella mechanical circulatory support device in ITaly: the IMP-IT registry","volume":"15","author":"Chieffo","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2025.01.010_bb0100","doi-asserted-by":"crossref","unstructured":"O'NEILL WW, SCHREIBER T, WOHNS DHW, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella registry. J. Interv. Cardiol. 2014;27:1\u201311.","DOI":"10.1111\/joic.12080"},{"key":"10.1016\/j.carrev.2025.01.010_bb0105","first-page":"338","article-title":"Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience","volume":"8","author":"Ouweneel","year":"2019","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.carrev.2025.01.010_bb0110","first-page":"7","article-title":"Influence of timing and predicted risk on mortality in Impella-treated infarct-related cardiogenic shock patients","author":"Sch\u00e4fer","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.carrev.2025.01.010_bb0115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.amjcard.2016.11.037","article-title":"Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock","volume":"119","author":"Basir","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.carrev.2025.01.010_bb0120","first-page":"12","article-title":"Early utilization of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the National Cardiogenic Shock Initiative","author":"Basir","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.carrev.2025.01.010_bb0125","first-page":"467","article-title":"Use of the Impella device for acute coronary syndrome complicated by cardiogenic shock - experience from a single heart center with analysis of long-term mortality","volume":"28","author":"Schroeter","year":"2016","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2025.01.010_bb0130","first-page":"149","article-title":"Long term survival after early unloading with Impella CP \u00ae in acute myocardial infarction complicated by cardiogenic shock","volume":"9","author":"Loehn","year":"2020","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.carrev.2025.01.010_bb0135","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2025.01.010_bb0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11239-005-0938-0","article-title":"Thrombolysis and Counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS trial","volume":"19","author":"Magnus Ohman","year":"2005","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.carrev.2025.01.010_bb0145","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","article-title":"Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock","volume":"26","author":"Thiele","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.carrev.2025.01.010_bb0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.acvd.2019.10.005","article-title":"Mechanical circulatory support with the Impella\u00ae LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: the IMPELLA-STIC randomized study","volume":"113","author":"Bochaton","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.carrev.2025.01.010_bb0155","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2025.01.010_bb0160","doi-asserted-by":"crossref","unstructured":"Buda KG, Hryniewicz K, Eckman PM, et al. Early vs. Delayed Mechanical Circulatory Support in Patients with Acute Myocardial Infarction and Cardiogenic Shock. Eur Heart J Acute Cardiovasc Care. 2024. Published onlineMarch 19, 2024. https:\/\/doi.org\/10.1093\/ehjacc\/zuae034.","DOI":"10.1093\/ehjacc\/zuae034"},{"key":"10.1016\/j.carrev.2025.01.010_bb0165","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jacc.2024.04.069","article-title":"Serial shock severity assessment within 72 hours after diagnosis","volume":"84","author":"Ton","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2025.01.010_bb0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13054-020-2816-8","article-title":"Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock","volume":"24","author":"Udesen","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.carrev.2025.01.010_bb0175","doi-asserted-by":"crossref","first-page":"e1585","DOI":"10.4244\/EIJ-D-18-00684","article-title":"Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model","volume":"14","author":"M\u00f8ller-Helgestad","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2025.01.010_bb0180","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0735-1097(03)00084-6","article-title":"Left ventricular support by catheter-Mountedaxial flow pump reduces infarct size","volume":"41","author":"Meyns","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2025.01.010_bb0185","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jchf.2015.06.010","article-title":"Mechanical pre-conditioning with acute circulatory support before reperfusion limits infarct size in acute myocardial infarction","volume":"3","author":"Kapur","year":"2015","journal-title":"JACC Heart Fail"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:03:15Z","timestamp":1762570995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":37,"alternative-id":["S1553838925000259"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.01.010","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of the DanGer Shock trial to randomized cardiogenic shock trials and real-world registries","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}